(GSIE) Goldman Sachs ActiveBeta - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814301079
GSIE: ETF, Equity, International, Developed, Markets
The Goldman Sachs ActiveBeta International Equity ETF is designed to provide investors with diversified exposure to developed international markets, excluding the United States. By tracking a specific index, the fund aims to capture the performance of a broad range of equity securities from mature economies outside of the US.
The funds investment strategy involves holding at least 80% of its assets in securities that are part of its underlying index, including depositary receipts and underlying stocks represented by these receipts. This approach allows the ETF to provide a comprehensive representation of the international developed market equity landscape.
Analyzing the ETFs recent performance, we observe a bullish trend indicated by its current price being above its 20-day Simple Moving Average (SMA20) and 50-day Simple Moving Average (SMA50). The Average True Range (ATR) suggests a relatively stable volatility profile. With the current price near its 52-week high, we can anticipate a potential consolidation or a slight pullback. However, given the overall upward trend and the funds AUM of over $4 billion, we forecast a continued positive trajectory in the short to medium term.
Using a combination of technical and fundamental analysis, our forecast suggests that GSIE will continue to perform well, driven by its diversified portfolio and the overall health of the international developed markets. We anticipate the ETF to potentially reach new highs in the coming months, driven by a favorable macroeconomic environment and the funds robust investment strategy. Investors should monitor the ETFs price action relative to its SMA50 and SMA200, as well as its ATR, to gauge potential entry and exit points.
For further information on the Goldman Sachs ActiveBeta International Equity ETF, investors can visit the GSAM Funds website at http://www.gsamfunds.com, where they can access detailed fund information, performance data, and other relevant resources to inform their investment decisions.
Additional Sources for GSIE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
GSIE ETF Overview
Market Cap in USD | 4,027m |
Category | Foreign Large Blend |
TER | 0.25% |
IPO / Inception | 2015-11-06 |
GSIE ETF Ratings
Growth Rating | 62.6 |
Fundamental | - |
Dividend Rating | 49.0 |
Rel. Strength | 4.94 |
Analysts | - |
Fair Price Momentum | 38.38 USD |
Fair Price DCF | - |
GSIE Dividends
Dividend Yield 12m | 1.57% |
Yield on Cost 5y | 2.52% |
Annual Growth 5y | 21.15% |
Payout Consistency | 85.2% |
Payout Ratio | % |
GSIE Growth Ratios
Growth Correlation 3m | 93.8% |
Growth Correlation 12m | 68.2% |
Growth Correlation 5y | 66.1% |
CAGR 5y | 11.38% |
CAGR/Max DD 5y | 0.38 |
Sharpe Ratio 12m | 1.41 |
Alpha | 10.03 |
Beta | 0.732 |
Volatility | 13.57% |
Current Volume | 340.6k |
Average Volume 20d | 427.9k |
As of June 29, 2025, the stock is trading at USD 39.57 with a total of 340,603 shares traded.
Over the past week, the price has changed by +3.33%, over one month by +1.89%, over three months by +10.71% and over the past year by +21.36%.
Yes. Based on ValueRay´s Analyses, Goldman Sachs ActiveBeta (NYSE ARCA:GSIE) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.59 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GSIE is around 38.38 USD . This means that GSIE is currently overvalued and has a potential downside of -3.01%.
Goldman Sachs ActiveBeta has no consensus analysts rating.
According to our own proprietary Forecast Model, GSIE Goldman Sachs ActiveBeta will be worth about 43.8 in June 2026. The stock is currently trading at 39.57. This means that the stock has a potential upside of +10.69%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 43.8 | 10.7% |